133 related articles for article (PubMed ID: 38280573)
1. Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia.
Takada S; Weitering TJ; van Os NJH; Du L; Pico-Knijnenburg I; Kuipers TB; Mei H; Salzer E; Willemsen MAAP; Weemaes CMR; Pan-Hammarstrom Q; van der Burg M
J Allergy Clin Immunol; 2024 May; 153(5):1392-1405. PubMed ID: 38280573
[TBL] [Abstract][Full Text] [Related]
2. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
Pan-Hammarström Q; Dai S; Zhao Y; van Dijk-Härd IF; Gatti RA; Børresen-Dale AL; Hammarström L
J Immunol; 2003 Apr; 170(7):3707-16. PubMed ID: 12646636
[TBL] [Abstract][Full Text] [Related]
3. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
[No Abstract] [Full Text] [Related]
4. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity.
Driessen GJ; Ijspeert H; Weemaes CM; Haraldsson Á; Trip M; Warris A; van der Flier M; Wulffraat N; Verhagen MM; Taylor MA; van Zelm MC; van Dongen JJ; van Deuren M; van der Burg M
J Allergy Clin Immunol; 2013 May; 131(5):1367-75.e9. PubMed ID: 23566627
[TBL] [Abstract][Full Text] [Related]
5. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
Staples ER; McDermott EM; Reiman A; Byrd PJ; Ritchie S; Taylor AM; Davies EG
Clin Exp Immunol; 2008 Aug; 153(2):214-20. PubMed ID: 18505428
[TBL] [Abstract][Full Text] [Related]
6. Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia.
Zielen S; Duecker RP; Woelke S; Donath H; Bakhtiar S; Buecker A; Kreyenberg H; Huenecke S; Bader P; Mahlaoui N; Ehl S; El-Helou SM; Pietrucha B; Plebani A; van der Flier M; van Aerde K; Kilic SS; Reda SM; Kostyuchenko L; McDermott E; Galal N; Pignata C; Pérez JLS; Laws HJ; Niehues T; Kutukculer N; Seidel MG; Marques L; Ciznar P; Edgar JDM; Soler-Palacín P; von Bernuth H; Krueger R; Meyts I; Baumann U; Kanariou M; Grimbacher B; Hauck F; Graf D; Granado LIG; Prader S; Reisli I; Slatter M; Rodríguez-Gallego C; Arkwright PD; Bethune C; Deripapa E; Sharapova SO; Lehmberg K; Davies EG; Schuetz C; Kindle G; Schubert R
J Clin Immunol; 2021 Nov; 41(8):1878-1892. PubMed ID: 34477998
[TBL] [Abstract][Full Text] [Related]
7. Alternative end joining during switch recombination in patients with ataxia-telangiectasia.
Pan Q; Petit-Frére C; Lähdesmäki A; Gregorek H; Chrzanowska KH; Hammarström L
Eur J Immunol; 2002 May; 32(5):1300-8. PubMed ID: 11981817
[TBL] [Abstract][Full Text] [Related]
8. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
[TBL] [Abstract][Full Text] [Related]
9. [Ataxia telangiectasia syndrome: clinical picture and immunological abnormalities].
Pietrucha B; Kmieć T; Mikołuć B; Bernatowska E; Jastrzebska-Piotrowska J; Pac M; Wolska-Kuśnierz B; Kuczyński D
Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S1-7. PubMed ID: 15045861
[TBL] [Abstract][Full Text] [Related]
10. Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation.
Pan-Hammarström Q; Lähdesmäki A; Zhao Y; Du L; Zhao Z; Wen S; Ruiz-Perez VL; Dunn-Walters DK; Goodship JA; Hammarström L
J Exp Med; 2006 Jan; 203(1):99-110. PubMed ID: 16390936
[TBL] [Abstract][Full Text] [Related]
11. Defective B-cell memory in patients with Down syndrome.
Verstegen RHJ; Driessen GJ; Bartol SJW; van Noesel CJM; Boon L; van der Burg M; van Dongen JJM; de Vries E; van Zelm MC
J Allergy Clin Immunol; 2014 Dec; 134(6):1346-1353.e9. PubMed ID: 25159464
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
Lumsden JM; McCarty T; Petiniot LK; Shen R; Barlow C; Wynn TA; Morse HC; Gearhart PJ; Wynshaw-Boris A; Max EE; Hodes RJ
J Exp Med; 2004 Nov; 200(9):1111-21. PubMed ID: 15504820
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: ATM Influences Germinal Center Integrity.
Nicolas L; Cols M; Smolkin R; Fernandez KC; Yewdell WT; Yen WF; Zha S; Vuong BQ; Chaudhuri J
J Immunol; 2019 Jun; 202(11):3137-3142. PubMed ID: 31028119
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-telangiectasia: Immunodeficiency and survival.
van Os NJH; Jansen AFM; van Deuren M; Haraldsson A; van Driel NTM; Etzioni A; van der Flier M; Haaxma CA; Morio T; Rawat A; Schoenaker MHD; Soresina A; Taylor AMR; van de Warrenburg BPC; Weemaes CMR; Roeleveld N; Willemsen MAAP
Clin Immunol; 2017 May; 178():45-55. PubMed ID: 28126470
[TBL] [Abstract][Full Text] [Related]
15. A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.
Minto H; Mensah KA; Reynolds PR; Meffre E; Rubtsova K; Gelfand EW
Clin Immunol; 2019 Mar; 200():55-63. PubMed ID: 30639167
[TBL] [Abstract][Full Text] [Related]
16. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.
Moeini Shad T; Yousefi B; Amirifar P; Delavari S; Rae W; Kokhaei P; Abolhassani H; Aghamohammadi A; Yazdani R
J Clin Immunol; 2021 Jan; 41(1):76-88. PubMed ID: 33052516
[TBL] [Abstract][Full Text] [Related]
17. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients.
Amirifar P; Mehrmohamadi M; Ranjouri MR; Akrami SM; Rezaei N; Saberi A; Yazdani R; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2022 Jan; 42(1):72-84. PubMed ID: 34628594
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Granulomatosis and Class Switching Defect as a Presenting Sign in Ataxia-Telangiectasia: First Case from the National Iranian Registry and Review of the Literature.
Amirifar P; Yazdani R; Moeini Shad T; Ghanadan A; Abolhassani H; Lavin M; Sotoudeh S; Aghamohammadi A
Immunol Invest; 2020 Aug; 49(6):597-610. PubMed ID: 31762358
[TBL] [Abstract][Full Text] [Related]
19. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.
Stray-Pedersen A; Jónsson T; Heiberg A; Lindman CR; Widing E; Aaberge IS; Borresen-Dale AL; Abrahamsen TG
Clin Exp Immunol; 2004 Jul; 137(1):179-86. PubMed ID: 15196260
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Transplantation Restores Naïve T-Cell Populations in
Duecker R; Baer PC; Buecker A; Huenecke S; Pfeffermann LM; Modlich U; Bakhtiar S; Bader P; Zielen S; Schubert R
Front Immunol; 2019; 10():2785. PubMed ID: 31849966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
